ANDA 062032

PARKE DAVIS

FDA Drug Application

Application #062032

Application Sponsors

ANDA 062032

PARKE DAVIS

Marketing Status

• Discontinued: 001
• Discontinued: 002

Application Products

001	TABLET;ORAL	EQ 250MG BASE	0	ERYPAR	ERYTHROMYCIN STEARATE
002	TABLET;ORAL	EQ 500MG BASE	0	ERYPAR	ERYTHROMYCIN STEARATE

FDA Submissions

ORIG

1

AP

1977-08-24

Submissions Property Types

ORIG

1

Null

29

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62032
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)